About this event

  • Date and time Mon 16 Nov 2020 from 12:30pm to 5:00pm
  • Location Online
  • Organised by Oncology

Following the previous successes of the RSM global oncology event, we are pleased to announce that the 5th year of this important meeting is going to take place in a webinar format.

LGCW

This webinar is part of the London Global Cancer Week 2020 - a series coordinated with over 20 different events providing a comprehensive picture of the impact of the rising incidence of cancer in emerging countries

Join this global movement to address the disparities in cancer care in low and middle income countries, and learn how to address this through collaborative networks. Once again, we bring together healthcare professionals from around the world to share their experiences and increase awareness of topical issues globally faced in oncology.

Participants can expect to understand:

  • Innovations through digital and other technology, which will improve cancer control in low and middle income settings
  • The global movement to eliminate cervical cancer, which could be the most significant achievement of our generation
  • How current research in global oncology is improving cancer outcomes

A CPD certificate with 3 CPD credits will be issued to those joining the webinar live as well as those who watch the recording afterwards. Certificates will be issued 7 days after the webinar to those who watch it live and after 30 days for those that watch the recording. 

Join in the conversation online using #RSMCancerLMIC #LondonGlobalCancer
Follow us on Twitter: @RoySocMed and @LGCW2020

Registration for this webinar will close 2 hours prior to the start time. You will receive the webinar link 2 hours before the meeting. Late registrations will not be accepted.

Webinar recordings will be available for registered delegates up to 30 days after the live webinar, via Zoom. The link will be sent 24 hours after the webinar takes place. 

This webinar will be recorded and stored by the Royal Society of Medicine and may be distributed in future on various internet channels.  

 

Please note, due to the COVID-19 breakout this year’s prize has been cancelled. Therefore the submission deadline has been extended to 2021. If you have already submitted an abstract, you have until the new deadline to make any changes. The winner and top 10 abstracts will be invited to present at the 2021 meeting.

CALL FOR ABSTRACTS: Vanessa Moss annual prize

Prizes:

  • Winner of best abstract - £250 and invited for oral presentation
  • Top 10 abstracts – poster presentation

Submission deadline: Sunday 27 June 2021

Open to:

  • Any scientist or healthcare professional working in the field of global cancer control
  • HICs and LMICs

Abstract guidelines:

Submit an abstract of 400 words maximum, including background, methods, results and discussion. The abstract should be on collaborative research/service delivery in which the applicant has been significantly involved, in global cancer control, focusing on LMICs as defined by the world bank group. The project may be clinical or scientific and the work may have been published previously (but not before 2018).

Judging panel will include oncologists and experts in the field of global cancer care who will consider the originality and the impact of the research on the quality of care for patients with cancer in LMICs, within the context of the resources available to the host institution.

The winner must agree to attend the conference. Standard travel expenses will covered by the RSM Oncology Section.

Submit your abstract >>

For further information please contact oncology@rsm.ac.uk.

Key speakers

Dr Bente Mikkelsen

Dr Bente Mikkelsen

Director, Non-Communicable Diseases, WHO Headquarters, Switzerland

Speaker's biography

Dr Bente Mikkelsen was formerly director of division of noncommunicable diseases and promoting health through the life-course at the World Health Organization Regional Office for Europe (Copenhagen, Denmark), head of secretariat for the global coordination mechanism on the prevention and control of noncommunicable diseases (WHO GCM/NCD) at the World Health Organization Headquarters (Geneva, Switzerland) from its inception in 2014, and former CEO of the Southern and Eastern Norway Regional Health Authority.

 

Dr Mikkelsen is trained as a Gynaecologist and Obstetrician and holds a Master’s degree in Health Administration and Management from the University of Oslo. Her current focus is on achieving the SDGs through the reduction of premature deaths from NCDs in the context of WHO General Programme of Work, and working across sectors with multi-stakeholders, within and beyond the health sector using innovation, implementation research, health literacy and new technologies.

Professor Mary Gospodarowicz

Professor Mary Gospodarowicz

Radiation Oncologist, Princess Margaret Cancer Centre

Speaker's biography

Mary Gospodarowicz is a professor at the University of Toronto, radiation oncologist with longstanding interest in genitourinary cancers and lymphomas. Her research focuses on clinical trials evaluating radiation therapy, image-guided precision radiotherapy, and cancer survivorship. Her current interests include global cancer control, global access to radiotherapy, and quality cancer care. She has authored close to 400 manuscripts.

 

Dr Gospodarowicz is the past-president of the Union for International Cancer Control (UICC). She spearheaded the Lancet Oncology Commission on “Expanding the global access to radiotherapy”. She continues to contribute to UICC and is currently a member of the board of directors of the City Cancer Challenge. She is an honorary fellow of the Royal College of Radiologists and has received other awards, including the ASTRO Gold Medal.

Dr May Abdel-Wahab

Dr May Abdel-Wahab

Director, Human Health Programme, International Atomic Energy Agency (IAEA)

Speaker's biography

Dr May Abdel-Wahab's main areas of focus include healthcare access and training, as well as novel solutions to address disparity and diversity issues. She has served as a member and chair, on the United Nations Interagency Task Force Steering committee (UNIATF) on prevention and control of noncommunicable diseases (NCDs), which coordinates UN-wide activities in NCDs amongst others. As a member of the UN Joint Programme on the Cervical Cancer Control Steering Committee, she is working at the global and national level with participating countries to support a national comprehensive cervical cancer control programme. She is also a steering committee member of the Lancet Oncology Commission on Imaging and Nuclear Medicine, studying cost and access in oncology. She has served as chair of the ASTRO Committee for Healthcare Access & Training and co-chair of the Integration of Health Enterprise in Radiation Oncology (IHE-RO) Planning Committee, working on interconnectivity issues at various levels of patient care.

 

Dr Wahab is an avid lecturer and has published widely. During her time as a residency program director, she has developed particular interest in education and curriculum development and has organized numerous symposia and scientific meetings. She has also served on advisory boards, expert panels, and professional journal editorial boards. She was principal investigator on Phase I and Phase II clinical trials and studied the interaction of novel GHRH-antagonists and radiation in her lab in close collaboration with Dr. Andrews Schally’s lab. Prior to joining the IAEA, she was section head of GI radiation oncology at the Cleveland Clinic, USA, and Professor at the Cleveland Clinic Lerner School of Medicine, Case Western University. Her research focused on prostate and GI cancers as well as quality assurance and access in radiotherapy. She is a fellow of both the American Board of Radiology (ACR) and the American Society of Radiation Oncology (ASTRO) and was featured on the Best Doctors in America listing, among other honors.

Dr Ophira Ginsburg

Dr Ophira Ginsburg

Director Perlmutter Cancer Center High Risk Program, New York University, New York, US

Speaker's biography

Dr Ophira Ginsburg is a medical oncologist and global women’s health researcher with technical and policy expertise in noncommunicable diseases prevention and management.  She is the director of the high-risk cancer genetics program and associate professor in the section for global health, department of population health at New York University School of Medicine. Formerly based at the University of Toronto, from 2015 to 2016 she was a medical officer at WHO and continues to serve as a consultant to several UN agencies, providing technical assistance to member states on national cancer control planning and policies.

 

Over the last 15 years, Dr Ophira Ginsburg developed an inter-disciplinary collaborative program of research, education, and policy guidance in cancer control, with colleagues on five continents. The overarching aim of her work is to improve equitable access to early detection for breast and cervical cancer in low-income and middle-income countries. She also conducts public health research to reduce cancer disparities for women in underserved communities in North America, and is leading a new study funded by the U.S. National Institutes of Health (“Cancer Moonshot” program), to improve access to cancer genetics services through primary care clinics in the New York area.

Dr Partha Basu

Dr Partha Basu

Head, Screening Group, International Agency for Research on Cancer

Speaker's biography

Dr Partha Basu is head of screening group of International Agency for Research on Cancer (IARC). He was head of gynecological oncology at Chittaranjan National Cancer Institute, India before joining IARC in 2015.

 

His current research projects include cohort study to evaluate single dose of HPV vaccine, RCT to evaluate a new Indian HPV vaccine, RCT to evaluate thermal ablation, evaluation of artificial intelligence for cervical cancer early detection, study of vaginal microbiome in HIV+ women, RCT to evaluate clinical breast examination, evaluation of automated breast ultrasound, evaluation of cancer screening programmes in Europe and Latin America, and evaluation of colorectal cancer screening in Mediterranean Region. These projects are funded by National Institute of Health (USA), Gates Foundation, American Cancer Society, MRC (UK), Norwegian Research Council, Swiss Cancer Research, Lalla Salma Foundation (Morocco), Indo-American Cancer Association, etc. Dr Basu's publications can be accessed here

Professor Richard Sullivan

Professor Richard Sullivan

Chair, Cancer and Global Health, King’s College London and Guy's and St Thomas' NHS Foundation Trust

Speaker's biography

Professor Richard Sullivan is professor of cancer and global health at King’s College London, and director of the King’s Institute of Cancer Policy and co-director of the Conflict and Health Research Group. As well as holding a number of visiting chairs, Professor Richard Sullivan is an non-communicable disease (NCD) advisor to the World Health Organization (WHO), civil-military advisor to Save the Children, and a member of the National Cancer Grid of India.

 

His research focuses on global cancer policy and planning, and health systems strengthening, particularly fragile and conflict settings. Professor Richard Sullivan’s research teams have programs in capacity building in conflict and health across the Middle East and North Africa (r4hc-mena.org), as well as programmes in women’s health, digital innovation (VR enhanced surgery) and a wide range of global health security projects. Professor Sullivan qualified in medicine and trained in surgery (urology), gaining his PhD in biochemistry from University College London. As well as working as research and development lead in industry he was also clinical director of Cancer Research UK, one of the world’s largest research funders between 1999 and 2008.

Agenda

View programme

Organisers: Dr Katie Wakeham, FRCR PhD, Clinical Oncologist, Brighton and Sussex University Hospitals and Dr Pippa Lewis, MBBS MSc FRCR National Radiotherapy Clinical Fellow

Welcome and introduction

Professor Richard Sullivan, Institute of Cancer Policy, Conflict and Health Research Group, King’s College London

Delivery of cancer services

Maintaining oncology care in the context of COVID-19

Professor Warren Phipps, Medical Director, UCI-Fred Hutch Collaboration UCI/Hutchinson Center Cancer Alliance

IAEA activities and Covid-19 assistance to Member states

Dr May Abdel-Wahab, Director, Human Health Programme, International Atomic Energy Agency (IAEA)

The City Cancer Challenge approach during COVID-19: Collaboration and shared experience

Ms Isabel Mestres, Director, Global Public Affairs, City Cancer Challenge

Panel discussion
Comfort break

Focus on cervical cancer

Introduction

Dr Hannah Tharmalingam, Vice-President, Clinical Oncology, Royal College of Radiologists

WHO call to action to eliminate cervical cancer and the implications of a global pandemic

Dr Partha Basu, Head, Screening Group, International Agency for Research on Cancer

The impact of Covid-19 on global cancer outcomes: The example of cervical cancer elimination

Dr Karen Canfell, Director Cancer Research Division, Cancer Council NSW and Adjunct Professor, Faculty of Medicine and Health, University of Sydney, Australia

COVID, women, and cancer

Dr Ophira Ginsburg, Associate Professor, Section for Global Health, Department of Population Health, New York University

Panel discussion
Comfort break

Research and innovations in global cancer care post COVID-19

Introduction

Professor Mary Gospodarowicz, Radiation Oncologist, Princess Margaret Cancer Centre

Research engagement in LMICs in the wake of a global pandemic

Dr Verna Vanderpuye, Senior Consultant Oncologist, National Center for Radiotherapy, Oncology and Nuclear Medicine, Korle-Bu Teaching Hospital, Accra Ghana

Innovations in radiotherapy provision for LMICs – using lessons learned from COVID-19 for benefit

Dr Manjit Dosanjh, Honorary CERN Staff, European Organization for Nuclear Research (CERN), Switzerland, Visiting Professor, University of Oxford and Project Leader, STELLA (Smart Technologies to Extend Lives with Linear Accelerators)

Panel discussion
Closing remarks

Dr Bente Mikkelsen, Director, Non-Communicable Diseases, WHO Headquarters, Switzerland

End of webinar

Location

Online

Disclaimer: All views expressed in this webinar are of the speakers themselves and not of the RSM.

Special rates for difficult times 

The RSM wishes to offer healthcare professionals continued learning opportunities during the coronavirus pandemic. The RSM’s COVID-19 online events are available free of charge, while there will be small charges to register for other online education. These fees will enable the RSM to continue its programme of activities and will apply during the course of the pandemic.  

Man searching computer

Join the RSM and get unlimited digital learning and e-resources access

The RSM has an extensive digital learning and online e-resources platform. As a member you'll enjoy unlimited digital learning any time you need and access to e-journals, e-books and 7 huge medical databases to support your clinical decision-making and research.

Our e-resources are updated continuously to ensure you receive the cutting edge knowledge you need. 

 

Become a member